Tamara S. Thevarajah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tamara S. Thevarajah has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Alexis Quezada
1 shared publicationAmber Alcorn
1 shared publicationAnna G. Guzman
1 shared publicationAnne M. Lynch
Department of Ophthalmology, University of Colorado School of Medicine, Aurora, USA
1 shared publicationBrandie D. Wagner
Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, USA
1 shared publication- Courtney Denton Dinardo
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA
1 shared publication
Latest Publications
- Open Access
- 16 April 2026
- Published by Elsevier in Blood Neoplasia
- Vol. 3 (3)
The KDM-family inhibitor JIB-04 sensitizes AML cells to venetoclax by inducing a ferroptosis-like phenotype
- 16 April 2026
- Published by Elsevier in Blood Neoplasia
- Vol. 3 (3)
Open AccessThe KDM-family inhibitor JIB-04 sensitizes AML cells to venetoclax by inducing a ferroptosis-like phenotype
- 2 March 2024
- Published by Springer Nature in Journal of Perinatology
- Vol. 44 (7) , 935-940
The relationship between severe hypertensive diseases of pregnancy and moderate-severe bronchopulmonary dysplasia
Objective Determine the association between severe hypertensive disease of pregnancy (HDP) with moderate-severe bronchopulmonary dysplasia (BPD) in preterm infants (< 31 weeks’ gestation). Study Design Preterm birth cohort study of 693 mother-infant dyads. Severe HDP was defined as severe preeclampsia, HELLP syndrome or eclampsia. The outcome was moderate-severe BPD classified at 36 weeks corrected gestational age, per the NICHD Consensus statement. Results 225 (32%) mothers developed severe HDP and 234 (34%) infants had moderate-severe BPD. There was an interaction between severe HDP and gestational age (p = 0.03). Infants born at < 25 weeks gestation to mothers with HDP had increased odds for moderate-severe BPD compared to infants of normotensive mothers delivering at the same gestational age. Infants born > 28 weeks to mothers with severe HDP had decreased odds for the outcome, though not statistically significant. Conclusions Severe HDP has a differential effect on the development of moderate-severe BPD based on gestational age.
- 2 March 2024
- Published by Springer Nature in Journal of Perinatology
- Vol. 44 (7) , 935-940
The relationship between severe hypertensive diseases of pregnancy and moderate-severe bronchopulmonary dysplasia
Objective Determine the association between severe hypertensive disease of pregnancy (HDP) with moderate-severe bronchopulmonary dysplasia (BPD) in preterm infants (< 31 weeks’ gestation). Study Design Preterm birth cohort study of 693 mother-infant dyads. Severe HDP was defined as severe preeclampsia, HELLP syndrome or eclampsia. The outcome was moderate-severe BPD classified at 36 weeks corrected gestational age, per the NICHD Consensus statement. Results 225 (32%) mothers developed severe HDP and 234 (34%) infants had moderate-severe BPD. There was an interaction between severe HDP and gestational age (p = 0.03). Infants born at < 25 weeks gestation to mothers with HDP had increased odds for moderate-severe BPD compared to infants of normotensive mothers delivering at the same gestational age. Infants born > 28 weeks to mothers with severe HDP had decreased odds for the outcome, though not statistically significant. Conclusions Severe HDP has a differential effect on the development of moderate-severe BPD based on gestational age.